I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A randomized double-blind placebo-controlled clinical trial..:
Rossignol, Jean-François
;
Bardin, Matthew C.
;
Fulgencio, Jessica
..
eClinicalMedicine. 45 (2022) - p. 101310 , 2022
Link:
https://doi.org/10.1016/j.eclinm.2022.101310
RT Journal T1
A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.eclinm.2022.101310&Exemplar=1&LAN=DE A1 Rossignol, Jean-François A1 Bardin, Matthew C. A1 Fulgencio, Jessica A1 Mogelnicki, Dena A1 Bréchot, Christian PB Elsevier BV YR 2022 SN 2589-5370 JF eClinicalMedicine VO 45 SP 101310 LK http://dx.doi.org/https://doi.org/10.1016/j.eclinm.2022.101310 DO https://doi.org/10.1016/j.eclinm.2022.101310 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)